High expression levels of membrane-associated RANKL on myeloma cells has been correlated with the presence of multiple bone lesions in myeloma patients.(12,13) In addition, the membrane form of RANKL can be released by proteases. This evidence concerns the gene TNFSF11 and plasma cell myeloma.